Unlocking the Potential of ATX-304: A Dual AMPK & Mitochondrial Activator for Obesity
Time: 10:00 am
day: Conference Day Two
Details:
- Delve into how ATX-304 activates AMPK and mitochondrial pathways to enhance energy expenditure, glucose, and lipid metabolism
- Review the ongoing Phase 1B study results in pre-diabetic, overweight/obese subjects, focusing on ATX-304’s effects on metabolic health and its potential role in chronic weight management
